The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Monoclonal antibodies to target epidermal growth factor receptor–positive tumors: A new paradigm for cancer therapy
Open accessAbstract
BACKGROUND: Traditional cytotoxic approaches to tumor management are associated with efficacy and toxicity limitations. Blockade of the epidermal growth factor receptor (EGFR) and its ligands is a novel approach to the treatment of human tumors that offers a noncytotoxic alternative to cancer treatment. METHODS: An English‐language literature search was conducted to identify studies assessing the in vitro and in vivo effects of EGFR blockade with an emphasis on approaches that use monoclonal antibody therapy. RESULTS: The EGF pathway regulates normal cellular processes and appears to be correlated with the development of malignancy. Approximately 30% of human tumors express EGFR, which has been reported to be correlated with poor prognosis and diminished disease‐free and overall survival in selected tumor types. A number of anti‐EGFR monoclonal antibodies have been developed, which currently are undergoing clinical trials in humans. Effective anti‐EGFR monoclonal antibodies compete with endogenous ligands, primarily EGF and transforming growth factor–α, for receptor ligand‐binding sites. Binding to EGFR blocks critical signaling pathways and interferes with the growth of tumors expressing EGFR. Anti‐EGFR monoclonal antibodies that currently are under study include IMC‐C225, EMD 55900, ICR 62, and ABX‐EGF. CONCLUSIONS: These antibodies have demonstrated promising results and appear to have been well tolerated. EGFR‐targeted therapy addresses important, unmet needs in the treatment of human tumors, particularly EGFR‐positive epithelial tumors including common malignancies of the head and neck, lung, and colon. Cancer 2002;94:1593–611. © 2002 American Cancer Society. DOI 10.1002/cncr.10372
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Untangling the ErbB signalling network
Yarden, Y., & Sliwkowski, M. X. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052073 · Cited by 6,974
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Carpenter, G., & Cohen, S. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.001205 · Cited by 2,909
Cobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S., Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2639 · Cited by 2,765
Epidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
GROWTH FACTOR RECEPTOR TYROSINE KINASES
Yarden, Y., & Ullrich, A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002303 · Cited by 1,838
Coussens, L., Yang-Feng, T. L., Liao, Y.-C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., et al. (1985) · Science · doi:10.1126/science.2999974 · Cited by 1,814
Carpenter, G., & Cohen, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38983-5 · Cited by 1,622
Baselga, J., Tripathy, D., Mendelsohn, J., Baughman, S., Benz, C. C., Dantis, L., Sklarin, N. T., Seidman, A. D., Hudis, C. A., Moore, J., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.737 · Cited by 1,380
RECEPTORS FOR EPIDERMAL GROWTH FACTOR AND OTHER POLYPEPTIDE MITOGENS
Carpenter, G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004313 · Cited by 1,281
Brizel, D. M., Albers, M. E., Fisher, S. R., Scher, R. L., Richtsmeier, W. J., Hars, V., George, S. L., Huang, A. T., & Prosnitz, L. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806183382503 · Cited by 1,127
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
Grandis, J. R., Melhem, M. F., Gooding, W. E., Day, R., Holst, V. A., Wagener, M. M., Drenning, S. D., & Tweardy, D. J. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.824 · Cited by 1,113
BindingDB (2025) · PubMed · doi:10.7270/q2dr317m · Cited by 843
Petit, A. M. V., Rak, J. W., Hung, M., Rockwell, P., Goldstein, N. I., FENDLY, B. M., & Kerbel, R. S. (1997) · Europe PMC (PubMed Central) · Cited by 836
Press, M. F., Bernstein, L., Thomas, P. A., Meisner, L. F., Zhou, J. Y., Ma, Y., Hung, G., Robinson, R. A., Harris, C., El-Naggar, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2894 · Cited by 802
Kawamoto, T., Sato, J. D., Le, A., Polikoff, J., Sato, G. H., & Mendelsohn, J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.5.1337 · Cited by 791
Goldstein, N. I., Prewett, M. C., Zuklys, K., Rockwell, P., & Mendelsohn, J. M. (1995) · PubMed · Cited by 785
Baselga, J., Pfister, D., Cooper, M. R., Cohen, R., Burtness, B., Bos, M., D’Andrea, G., Seidman, A., Norton, L., Gunnett, K., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.4.904 · Cited by 741
Huang, S., Bock, J. M., & Harari, P. M. (1999) · PubMed · Cited by 714
Perrotte, P., Matsumoto, T., Inoue, K., Kuniyasu, H., Eve, B. Y., Hicklin, D. J., Radinsky, R., & Dinney, C. P. (1999) · PubMed · Cited by 647
Ekstrand, A. J., James, C. D., Cavenee, W. K., Seliger, B., Pettersson, R. F., & Collins, V. P. (1991) · PubMed · Cited by 630
KLIJN, J. G. M., BERNS, P. M. J. J., SCHMITZ, P. I. M., & FOEKENS, J. A. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-3 · Cited by 597
Seshadri, R., Firgaira, F. A., Horsfall, D. J., McCaul, K., Setlur, V, & Kitchen, P. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.1936 · Cited by 528
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.
LoBuglio, A. F., Wheeler, R. H., Trang, J., Haynes, A., Rogers, K., Harvey, E. B., Sun, L., Ghrayeb, J., & Khazaeli, M. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4220 · Cited by 524
Horiot, J.-C., Bontemps, P., van den Bogaert, W., Le Fur, R., van den Weijngaert, D., Bolla, M., Bernier, J., Lusinchi, A., Stuschke, M., Lopez-Torrecilla, J., et al. (1997) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00079-0 · Cited by 506
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
Milas, L., Mason, K. A., Hunter, N. R., et al. (2000) · PubMed · Cited by 503
Wikstrand, C. J., Hale, L. P., Batra, S. K., Hill, M. L., Humphrey, P. A., Kurpad, S. N., McLendon, R. E., Moscatello, D. K., Pegram, C. N., & Reist, C. J. (1995) · PubMed · Cited by 469
Yamanaka, Y., Frieß, H., Kobrin, M. S., Büchler, M. W., Hg, B., & Korc, M. (1993) · PubMed · Cited by 461
Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.
Sato, J. D., Kawamoto, T., Le, A. D., Mendelsohn, J. M., Polikoff, J., & SATO, G. H. (1983) · PubMed · Cited by 458
Fan, Z., Baselga, J. M., Masui, H., & Mendelsohn, J. M. (1993) · PubMed · Cited by 456
Gill, G. N., Kawamoto, T., Cochet, C., Le, A., Sato, J. D., Masui, H., McLeod, C., & Mendelsohn, J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42857-2 · Cited by 455
Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers
Gullick, W. J. (1991) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072464 · Cited by 449
Bruns, C. J., Harbison, M. T., Davis, D. W., Portera, C. A., Tsan, R. Z., McConkey, D. J., Evans, D. B., Abbruzzese, J. L., Hicklin, D. J., & Radinsky, R. (2000) · PubMed · Cited by 422
Mayer, A., Takimoto, M., Fritz, E., Schellander, G., Kofler, K., & Ludwig, H. (1993) · Cancer · doi:10.1002/1097-0142(19930415)71:8<2454::aid-cncr2820710805>3.0.co;2-2 · Cited by 412
Baselga, J., Norton, L., Masui, H., Pandiella, A., Coplan, K., Miller, W. H., & Mendelsohn, J. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.16.1327 · Cited by 411
Nagane, M., Coufal, F. J., Lin, H., Bögler, O., Cavenee, W. K., & Huang, H.-J. S. (1996) · PubMed · Cited by 405
Rusch, V. W., Klimstra, D. S., Venkatraman, E. S., Pisters, P. W. T., Langenfeld, J. E., & Dmitrovsky, E. (1997) · PubMed · Cited by 401
Wu, X., Fan, Z., Masui, H., Rosen, N., & Mendelsohn, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117871 · Cited by 381
Grandis, J. R., Melhem, M. F., Barnes, E. L., & Tweardy, D. J. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960915)78:6<1284::aid-cncr17>3.0.co;2-x · Cited by 369
The type 1 (EGFR-related) family of growth factor receptors and their ligands
Prigent, S. A., & Lemoine, N. R. (1992) · Progress in Growth Factor Research · doi:10.1016/0955-2235(92)90002-y · Cited by 369
Intermolecular association of the p185 protein and EGF receptor modulates EGF receptor function
Wada, T., Qian, X., & Greene, M. I. (1990) · Cell · doi:10.1016/0092-8674(90)90697-d · Cited by 361
Wikstrand, C. J., McLendon, R. E., Friedman, A. H., & Bigner, D. D. (1997) · PubMed · Cited by 332
Ciardiello, F., Bianco, R., Damiano, V., Lorenzo, S. D., Pepe, S., Placido, S. D., Fan, Z., Mendelsohn, J. M., Bianco, A. R., & Tortora, G. (1999) · PubMed · Cited by 332
Yang, X., Jia, X., Corvalan, J. R. F., Wang, P., Davis, C., & Jakobovits, A. (1999) · PubMed · Cited by 328
Radinsky, R., Risin, S. A., Fan, D., Dong, Z., Bielenberg, D. R., Bucana, C. D., & Fidler, I. J. (1995) · PubMed · Cited by 321
Fontanini, G., Laurentiis, M. D., Vignati, S., Chinè, S., Lucchi, M., Silvestri, V., Mussi, A., Placido, S. D., Tortora, G., Bianco, A. R., et al. (1998) · PubMed · Cited by 306
Shin, D. M., Donato, N. J., Perez-Soler, R., Shin, H. J. C., Wu, J. Y., Zhang, P. G. Y., Lawhorn, K., Khuri, F. R., Glisson, B. S., Myers, J. N., et al. (2001) · PubMed · Cited by 298
Self-citationPeng, D., Fan, Z., Yang, L., DeBlasio, T., Scher, H. I., & Mendelsohn, J. M. (1996) · PubMed · Cited by 280
The epidermal growth factor receptor as a multifunctional allosteric protein
Schlessinger, J. (1988) · Biochemistry · doi:10.1021/bi00409a002 · Cited by 279
de Jong, J. S., van Diest, P. J., van der Valk, P., & Baak, J. P. A. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199801)184:1<53::aid-path6>3.0.co;2-7 · Cited by 257
Gille, J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.4.750 · Cited by 251
EGF, TGF-a, and EGF-R in Human Colorectal Adenocarcinoma
Messa, C., Russo, F., Gabriella Caruso, M., & Di Leo, A. (1998) · Acta Oncologica · doi:10.1080/028418698429595 · Cited by 251
Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma
Maurizi, M., Almadori, G., Ferrandina, G., Distefano, M., Romanini, M., Cadoni, G., Benedetti-Panici, P., Paludetti, G., Scambia, G., & Mancuso, S. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.525 · Cited by 250
Epidermal Growth Factor Protects Epithelial Cells against Fas-induced Apoptosis
Gibson, S., Tu, S., Oyer, R., Anderson, S. M., & Johnson, G. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17612 · Cited by 248
Prewett, M., Scher, H. I., Rockwell, P., Rockwell, R. F., Giorgio, N. A., Mendelsohn, J., & Goldstein, N. I. (1996) · Journal of Immunotherapy · doi:10.1097/00002371-199611000-00006 · Cited by 244
Goldman, R., Ben Levy, R., Peles, E., & Yarden, Y. (1990) · Biochemistry · doi:10.1021/bi00502a002 · Cited by 244
Veale, D., Kerr, N., Gibson, G., Kelly, P., & Harris, A. L. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.306 · Cited by 219
Kondapaka, S. B., Fridman, R. A., & Reddy, K. B. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970317)70:6<722::aid-ijc15>3.0.co;2-b · Cited by 216
Scher, H. I., Sarkis, A. S., Reuter, V., Cohen, D., Netto, G. J., Petrylak, D. P., LIANES, P., FUKS, Z. Y., Mendelsohn, J. M., & Cordon‐Cardo, C. (1995) · PubMed · Cited by 214
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer
Bartlett, J., Langdon, S., Simpson, B., Stewart, M., Katsaros, D., Sismondi, P., Love, S., Scott, W., Williams, A., Lessells, A., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.53 · Cited by 211
Klijn, J. G. (1992) · Endocrine Reviews · doi:10.1210/er.13.1.3 · Cited by 185
CHU, C. T., EVERISS, K. D., WIKSTRAND, C. J., BATRA, S. K., KUNG, H.-J., & BIGNER, D. D. (1997) · Biochemical Journal · doi:10.1042/bj3240855 · Cited by 184
Zhou, J.-R., Mukherjee, P., Gugger, E. T., Tanaka, T., Blackburn, G. L., & Clinton, S. K. (1999) · The Journal of Urology · doi:10.1097/00005392-199908000-00098 · Cited by 181
Volm, M., Rittgen, W., & Drings, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.106 · Cited by 178
Noonberg, S. B., & Benz, C. C. (2000) · Drugs · doi:10.2165/00003495-200059040-00003 · Cited by 173
Overholser, J. P., Prewett, M. C., Hooper, A. T., Waksal, H. W., & Hicklin, D. J. (2000) · Cancer · doi:10.1002/1097-0142(20000701)89:1<74::aid-cncr11>3.0.co;2-k · Cited by 165
EGF-R dependent regulation of keratinocyte survival
Rodeck, U., Jost, M., Kari, C., Shih, D.-T., Lavker, R. M., Ewert, D. L., & Jensen, P. J. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.2.113 · Cited by 164
Engebraaten, O., Bjerkvig, R., Pedersen, P., & Laerum, O. D. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530206 · Cited by 159
Fischer-Colbrie, J., Witt, A., Heinzl, H., Speiser, P., Czerwenka, K. F., Sevelda, P., & Zeillinger, R. (1997) · PubMed · Cited by 156
Fujino, S., Enokibori, T., Tezuka, N., Asada, Y., Inoue, S., Kato, H., & Mori, A. (1996) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00243-2 · Cited by 150
Gene amplification in human gliomas
Collins, V. P. (1995) · Glia · doi:10.1002/glia.440150309 · Cited by 149
The EGF Receptor System as a Target for Antitumor Therapy
Ennis, B. W., Lippman, M. E., & Dickson, R. B. (1991) · Cancer Investigation · doi:10.3109/07357909109018953 · Cited by 143
Prewett, M. C., Rothman, M., Waksal, H. W., Feldman, M. A., Bander, N. H., & Hicklin, D. J. (1998) · PubMed · Cited by 141
Treatment of cancer with radiation and drugs.
Tannock, I. F. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.12.3156 · Cited by 135
van de Vijver, M. J., Kumar, R., & Mendelsohn, J. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89475-7 · Cited by 122
Fox, S. B., Gatter, K. C., & Harris, A. L. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199607)179:3<232::aid-path505>3.0.co;2-a · Cited by 119
Reissmann, P. T., Koga, H., Figlin, R. A., Holmes, E. C., & Slamon, D. J. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050243 · Cited by 118
The EGF receptor: structure, regulation and potential role in malignancy.
Thompson, D. M., & Gill, G. N. (1985) · PubMed · Cited by 116
Patterns of epidermal growth factor receptor amplification in malignant gliomas.
Sauter, G., MAEDA, T., Waldman, F. M., Davis, R. L., & Feuerstein, B. G. (1996) · Europe PMC (PubMed Central) · Cited by 112
Price, J. T., Wilson, H. M., & Haites, N. E. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(96)00207-9 · Cited by 108
He, Y., Zeng, Q., Drenning, S. D., Melhem, M. F., Tweardy, D. J., Huang, L., & Grandis, J. R. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.14.1080 · Cited by 108
Xie, H., Turner, T., Wang, M., Singh, R. K., Siegal, G. P., & Wells, A. H. (1995) · Clinical & Experimental Metastasis · doi:10.1007/bf00118180 · Cited by 107
Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer.
Chow, N. H., Liu, H., Lee, E. I. C., Chang, C. J., Chan, S. H., Cheng, H., Tzai, T. S., & Lin, J. S. N. (1997) · PubMed · Cited by 106
Modjtahedi, H., Hickish, T., Nicolson, M. C., Moore, J. L., Styles, J., Eccles, S. A., Jackson, E., Salter, J., Sloane, J., Spencer, L., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.40 · Cited by 101
Protein factors which regulate cell motility
Rosen, E. M., & Goldberg, I. D. (1989) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02621258 · Cited by 99
Dimitroff, C. J., Klohs, W. D., Sharma, A., Pera, P. J., Driscoll, D. L., Veith, J. M., Steinkampf, R. W., Schroeder, M. C., Klutchko, S. R., Sumlin, A. B., et al. (1999) · Investigational New Drugs · doi:10.1023/a:1006367032156 · Cited by 96
Niikura, H., Sasano, H., Sato, S., & Yajima, A. (1997) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199701000-00010 · Cited by 91
Petrides, P. E., Bock, S., Bovens, J., Hofmann, R. W., & Jakse, G. (1990) · PubMed · Cited by 89
Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors
Han, E. K.-H., Lim, J. T. E., Arber, N., Rubin, M. A., Xing, W. Q., & Weinstein, I. B. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980501)35:2<117::aid-pros5>3.0.co;2-g · Cited by 84
Stragliotto, G., Vega, F., Stasiecki, P., Gropp, P., Poisson, M., & Delattre, J. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00592-7 · Cited by 82
Karnes, W. E., Weller, S. G., Adjei, P. N., Kottke, T. J., Glenn, K. S., Gores, G. J., & Kaufmann, S. H. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70312-9 · Cited by 79
Shibata, T., Kawano, T., Nagayasu, H., Okumura, K., Arisue, M., Hamada, J., Takeichi, N., & Hosokawa, M. (1996) · Tumor Biology · doi:10.1159/000217979 · Cited by 75
Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
Uckun, F. M., Narla, R. K., Jun, X., Zeren, T., Venkatachalam, T. K., Waddick, K. G., Rostostev, A., & Myers, D. E. (1998) · PubMed · Cited by 69
Hoffmann, T. K., Häfner, D., Balló, H., et al. (1998) · PubMed · Cited by 68
Chattopadhyay, A., & Carpenter, G. F. (2002) · Wiley eBooks · doi:10.1002/047120918x.emb0485 · Cited by 66
The genetic engineering of monoclonal antibodies
Owens, R. J., & Young, R. J. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90051-5 · Cited by 60
Prewett, M. C., Rockwell, P., Rose, C., & Goldstein, N. I. (1996) · International Journal of Oncology · doi:10.3892/ijo.9.2.217 · Cited by 41
A mouse/human chimeric anti-(ganglioside GD3) antibody with enhanced antitumor activities
Shitara, K., Kuwana, Y., Nakamura, K., Tokutake, Y., Ohta, S., Miyaji, H., Hasegawa, M., & Hanai, N. (1993) · Cancer Immunology Immunotherapy · doi:10.1007/bf01742253 · Cited by 38
ANZAI, H., Kitadai, Y., Bucana, C. D., Sanchez, R. R., Omoto, R., & Fidler, I. J. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10075-2 · Cited by 35
Lydon, N., Mett, H., Mueller, M. R., Becker, M. A., Cozens, R. M., Stover, D. R., Daniels, D., Traxler, P. M., & Buchdunger, E. (1998) · International Journal of Cancer · Cited by 27
Ciardiello, F., Caputo, R., Bianco, R., et al. (2000) · Cited by 21
Cited by
Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods
Huang, X., El-Sayed, I. H., Qian, W., & El-Sayed, M. A. (2006) · Journal of the American Chemical Society · doi:10.1021/ja057254a · Cited by 5,436
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,443
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201
Self-citationQuantum Dots and Their Multimodal Applications: A Review
Bera, D., Qian, L., Tseng, T.-K., & Holloway, P. H. (2010) · Materials · doi:10.3390/ma3042260 · Cited by 1,365
Metadata
- Authors
- Herbst, R. S., & Shin, D. M.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2002-03
- Volume
- 94
- Issue
- 5
- Pages
- 1593-1611
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2079286299
- Cited by
- 446
- References
- 105
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.